Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Stock
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
7.29M
-
Shares change
-
-928K
-
Total reported value, excl. options
-
$1.09M
-
Value change
-
-$144K
-
Number of buys
-
14
-
Number of sells
-
-12
-
Price
-
$0.15
Significant Holders of VYNE THERAPEUTICS INC COM - Stock (VYNE) as of Q4 2022
38 filings reported holding VYNE - VYNE THERAPEUTICS INC COM - Stock as of Q4 2022.
VYNE THERAPEUTICS INC COM - Stock (VYNE) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.29M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (1.65M shares), DSC Advisors, L.P. (1.57M shares), BlackRock Inc. (886K shares), RENAISSANCE TECHNOLOGIES LLC (867K shares), MILLENNIUM MANAGEMENT LLC (488K shares), GEODE CAPITAL MANAGEMENT, LLC (449K shares), STATE STREET CORP (210K shares), Tekla Capital Management LLC (135K shares), MACKENZIE FINANCIAL CORP (135K shares), and Cetera Advisor Networks LLC (115K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.